Buy Lonsurf Medicine | Signs, Interactions, Side Effects

 In a clinical trial, half of patients with metastatic colon or rectal cancer treated with LONSURF® (trifluridine and tipiracil) Tablets were still alive at 7.1 months and half of patients who received placebo were still alive at 5.3 months were alive. Worsening of disease or death occurred in 88% of patients treated with LONSURF and 94% of patients receiving placebo.

In the clinical trial, half of the patients with metastatic colon cancer treated with LONSURF were still alive at 5.7 months and half of the patients who received placebo were still alive at 3.6 months. Worsening of disease or death occurred in 85% of patients treated with LONSURF and 92% of patients receiving placebo.

 Signs and Important Safety Information

LONSURF is a prescription medicine used to treat adults

• Colorectal cancer that has spread to other parts of the body and has been previously treated or cannot receive certain chemotherapy drugs.

• A type of stomach cancer called gastric cancer, including cancer of the gastroesophageal junction that has spread to other parts of the body and who have been previously treated or cannot receive certain chemotherapy drugs.

Important Security Information

Serious side effects of LONSURF can occur, including:

• Low blood counts. Low blood count is common with LONSURF and can sometimes be serious and life-threatening. Low white blood cells can make you more likely to get serious infections that can lead to death. Your healthcare provider should perform blood tests before you receive LONSURF, on Day 15 during treatment with LONSURF, and as needed to check your blood cell count. Your healthcare provider may lower your dose of Lonsurf or stop Lonsurf if you have low white blood cell or platelet counts.

Before taking LONSURF, tell your healthcare provider about all of your medical conditions, including if you:

• have kidney or liver problems

• Are pregnant or planning to become pregnant. LONSURF may harm your unborn baby.

• Women may become pregnant: Your healthcare provider will confirm your pregnancy status before starting treatment with Lonsurf. You must use effective birth control during and for 6 months after your last dose of treatment with LONSURF. Tell your healthcare provider right away if you become pregnant.

• Men, during treatment and for 3 months after the last dose of LONSURF, you should use a condom during sex with female partners who are capable of becoming pregnant. Tell your healthcare provider right away if your partner becomes pregnant while taking Lonsurf.

• Are breast-feeding or planning to breast-feed. It is not known whether Lonsurf passes into your breast milk.

Tell your healthcare provider about all prescription and over-the-counter medicines, vitamins, and herbal supplements you take.

The most common side effects with Lonsurf include fatigue (tiredness, weakness), nausea, loss of appetite, diarrhea, vomiting, abdominal pain, and fever.

These are not all the possible side effects of Lonsurf. For more information, ask your healthcare provider. You can call your doctor for medical consultation about the side effects.

Location: New Delhi, Delhi, India

Comments

Post a Comment

Popular posts from this blog

What Is IDHIFA (Enasidenib)? Causes, Side Effects, Dosage

Image
  WHAT IS IDHIFA (Enasidenib)? IDHIFA Medicine IDHIFA is a prescription medicine used to treat people with acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation whose disease has come back or has not improved after previous treatment(s). It is not known if IDHIFA is safe and effective in children. IDHIFA may cause serious side effects, including: Differentiation Syndrome. Differentiation syndrome is a condition that affects your blood cells which may be life-threatening or lead to death if not treated. Differentiation syndrome has happened within 1 day and up to 5 months after starting IDHIFA. Check the following symptoms below. ·          fever ·          cough ·          shortness of breath ·          swelling of arms and legs ·         ...
Read more

The BEST HIV MEDICINE DISTRIBUTOR IN DELHI

Image
  If you're in search of an HIV medication distributor in Delhi, you've come to the right place. There are many options to choose from - NCPI+,Alleviareindia. GSNP+ and a few other brands. Here are some factors to consider. NCPI+ The NCPI+ HIV MEDICINE DISRIBUTOR IN DELHI works to provide HIV medications to people in need in the country. The medicines are incredibly expensive in the open market. However, the government is providing free antiretroviral drugs to 2.1 million people in India. The government procures these drugs through a tender process. The medicines are not readily available at the patient's home, so they need to be transported to the person who needs it most. There are several reasons for this. First, people need to be protected from police. While traveling, they need to present a pass issued by the government or a state AIDS control society. In some cases, police have torn people's green books, forcing them to go without access to the medicines. This has...
Read more

What is Byduron? What are their Side Effects?

Image
What is Bydureon (exenatide)? Bydureon is a brand-name medicine used to improve blood sugar levels in people with type 2 diabetes. It comes as a liquid suspension to be given by injection under the skin (subcutaneously). Bydureon contains a medicine called extended-release exenatide. Bydureon vs Bydureon BCise Bydureon BCise is another form of Bydureon. It contains the same medicine (extended-release exenatide). Bydureon and Bydureon BCise work in the same way and have very similar effects in the body. You push the autoinjector against your skin, and it injects the medicine automatically. There are fewer steps required to inject Bydureon using this autoinjector than using a syringe or pen injector. This can make Bydureon BCise easier to use than Bydureon. In clinical studies, Bydureon reduced hemoglobin A1c (HbA1c) by approximately 0.88 to 1.6 percent after 24 to 28 weeks of treatment. In the Bydureon BCise study, HbA1c was reduced by approximately 1.07 to 1.39 percent after ...
Read more